Sevelamer News

← Back to News Overview


Sevelamer currently has 0 news articles, with 20 predicted indications.

This page combines the AI-predicted indications for Sevelamer with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
  • Original indication: Renagel is indicated for the control of hyperphosphataemia in adult patients receiving  haemodialysis or peritoneal dialysis. Renagel should be used within the context of a multiple therapeutic...
  • Evidence level: L5
  • Predicted indications (20):
    • breast fibrocystic disease (92.5%)
    • blunt duct adenosis of breast (89.9%)
    • apocrine adenosis of breast (89.9%)
    • benign mammary dysplasia (88.9%)
    • HIV infectious disease (87.2%)
    • AIDS (86.4%)
    • breast abscess (83.6%)
    • fat necrosis of breast (83.6%)
    • lactation disease (83.4%)
    • neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter (83.2%)
    • simian immunodeficiency virus infection (82.8%)
    • feline acquired immunodeficiency syndrome (82.8%)
    • breast adenosis (82.2%)
    • congestive heart failure (80.2%)
    • AIDS related complex (79.8%)
    • congenital human immunodeficiency virus (79.8%)
    • acute pulmonary heart disease (79.4%)
    • ulceration of vulva (79.3%)
    • vulvar neoplasm (78.9%)
    • vulvitis (77.8%)

View full drug report →

No related news yet. When news mentions this drug, it will be collected and shown here automatically.

Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.

Copyright © 2026 藥提醒科技有限公司 (yao.care). For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.